Emanuela M Ghia

Title: Emanuela M Ghia: Innovator in Cancer Treatment

Introduction

Emanuela M Ghia is a prominent inventor based in San Diego, California. She has made significant contributions to the field of cancer treatment, particularly in addressing chemoresistant cancers. Her innovative approaches have the potential to improve therapeutic outcomes for patients suffering from challenging forms of cancer.

Latest Patents

Emanuela M Ghia holds a patent for a groundbreaking method titled "Combination treatment of chemoresistant cancers." This patent outlines compositions and methods for treating chemoresistant breast cancer. The methods involve administering a therapeutically effective amount of a chemotherapeutic agent, specifically paclitaxel, alongside a ROR-1 antagonist, cirmtuzumab. The patent also includes pharmaceutical compositions that combine these agents with a pharmaceutically acceptable excipient.

Career Highlights

Emanuela M Ghia is affiliated with the University of California, where she conducts her research and development in cancer therapies. Her work is characterized by a commitment to advancing medical science and improving patient care through innovative treatment strategies.

Collaborations

Emanuela has collaborated with notable colleagues, including Thomas James Kipps and Suping Zhang. These partnerships enhance her research efforts and contribute to the development of effective cancer treatments.

Conclusion

Emanuela M Ghia's contributions to cancer treatment through her innovative patent demonstrate her dedication to improving healthcare outcomes. Her work continues to inspire advancements in the fight against chemoresistant cancers.